Outcomes of allogeneic transplantation with non-myeloablative conditioning in patients with myelodysplastic and overlap syndromes

被引：0
|
作者：
Hilali, Ammar [1 ]
Hibbs, Stephen [1 ]
Davies, Jeff [1 ,2 ]
Smith, Matthew [1 ]
机构：
[1] Queen Mary Univ London, Barts Hlth Natl Hlth Serv NHS Trust, Dept Haematooncol, London, England
[2] Queen Mary Univ London, Barts Canc Inst, Ctr Haematooncol, London, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2021年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH2021-PO
引用
收藏
页码：227 / 228
页数：2
相关论文
共 50 条
  • [31] Reduced intensity (RIC) vs non-myeloablative (NMA) conditioning regimens prior to allogeneic hematopoietic stem cell transplantation (HSCT) in older patients (pts) with myelodysplastic syndromes (MDS) or myelodysplastic/myeloproliferative neoplasm (MDS/MPN)
    Jentzsch, M.
    Pfrepper, C.
    Linke, R.
    Doehring, C.
    Grimm, J.
    Beinicke, S.
    Haentschel, J.
    Hille, A.
    Poenisch, W.
    Vucinic, V.
    Franke, G. -N.
    Behre, G.
    Niederwieser, D.
    Schwind, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 61 - 61
  • [32] The role of allogeneic hematopoietic cell transplantation with non-myeloablative conditioning in chronic myeloid leukemia.
    Gurman, G
    Arat, M
    Soydan, E
    Dalva, K
    Ilhan, O
    Uysal, A
    Beksac, M
    BLOOD, 2001, 98 (11) : 375B - 376B
  • [33] Allogeneic stem cell transplantation using non-myeloablative conditioning regimens:: Results of the Mexican approach
    Ruiz-Argüelles, GJ
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (Suppl 1) : 376 - 379
  • [34] Pemphigus vulgaris treated with allogeneic hematopoietic stem cell transplantation following non-myeloablative conditioning
    Suslova, I. M.
    Theodoropoulos, D. S.
    Cullen, N. A. M.
    Tetarnikova, M. K.
    Tetarnikov, A. S.
    Kolchak, N. A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2010, 14 (09) : 785 - 788
  • [35] Comparing psychosocial profiles and outcomes between patients undergoing myeloablative and non-myeloablative allogeneic transplants
    Mclellan, L.
    Foster, L.
    Rybicki, L.
    Dabney, J.
    Visnosky, M.
    Bolwell, B.
    PSYCHO-ONCOLOGY, 2008, 17 (03) : S84 - S85
  • [36] Early and late gastrointestinal complications after allogeneic stem cell transplantation following myeloablative and non-myeloablative conditioning.
    Schulenburg, A
    Turetschek, K
    Wrba, F
    Vogelsang, H
    Greinix, HT
    Keil, F
    Mitterbauer, M
    Kalhs, P
    BLOOD, 2002, 100 (11) : 631A - 631A
  • [37] Non-myeloablative allogeneic transplantation in patients with relapsed or refractory multiple myeloma.
    Gerull, S
    Hegenbart, U
    Goerner, M
    Benner, A
    Moehler, T
    Goldschmidt, H
    Ho, AD
    BLOOD, 2004, 104 (11) : 755A - 755A
  • [38] Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection
    B J Byrne
    M Horwitz
    G D Long
    C Gasparetto
    K M Sullivan
    J Chute
    N J Chao
    D A Rizzieri
    Bone Marrow Transplantation, 2008, 41 : 39 - 43
  • [39] Non-Myeloablative Conditioning with Total Lymphoid Irradiation and ATG and Allogeneic Transplantation for Patients with Myelodysplastic Syndrome, Therapy-Related Myeloid Neoplasms, and Myeloproliferative Neoplasms.
    Benjamin, Jonathan
    Chhabra, Saurabh
    Kohrt, Holbrook E.
    Laport, Ginna G.
    Arai, Sally
    Johnston, Laura
    Miklos, David B.
    Shizuru, Judith A.
    Weng, Wen-Kai
    Negrin, Robert S.
    Lowsky, Robert
    BLOOD, 2012, 120 (21)
  • [40] Non-myeloablative allogeneic transplantation in patients with resistant/refractory Hodgkin's disease
    Pastano, R.
    Gigli, F.
    Rabascio, C.
    Calabrese, L.
    Martinelli, G.
    Peccatori, F.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S250 - S251
12345